Category: Pakistan

Posted on

Nikkiso Cosmodyne Commissions TGNO-1000 Developed for Float Glass Applications

TEMECULA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (Group), a subsidiary of Nikkiso Co., Ltd (Japan), is pleased to announce Nikkiso Cosmodyne recently commissioned its TGNO-1000 gaseous oxygen and nitrogen plant. The new plant targets float glass manufacturing and was sold to an industrial gases company.

The Nikkiso Cosmodyne TGNO is a cryogenic oxygen and nitrogen generator designed to produce three gaseous product streams: medium and high-pressure nitrogen gas and oxygen gas. The high-pressure nitrogen comes directly off the nitrogen column at approximately 8.5 bar(g). The medium pressure nitrogen stream comes from the oxygen column overhead and is boosted by a waste stream expander to approximately 2.3 bar(g). The gaseous oxygen comes directly off the oxygen column which runs at an elevated pressure of 2.3 bar(g). All this is accomplished at a low specific power of 0.27 KW/Nm3

The TGNO-1000 was configured with mostly preexisting components to meet the developmental needs of this multi-product plant. This allowed them to meet the stringent goals of their industrial gas customer, who is selling the molecules to the float glass customer. The plant also operates without an attendant, so can handle fluctuations in product demand without human intervention.

The prefabricated TGNO is delivered in pre-piped, pre-wired, easy-to-install modular sections. The chiller, adsorber beds, switching valves and turboexpander are mounted in a single skid, minimizing field work. The control room module houses the motor control center and required analyzers.

“This is Cosmodyne’s most recent effort to supply cryogenic systems and plants which allows our industrial gas customers to develop their market and compete effectively, according to George Pappagelis, President of Cosmodyne Process Systems. “The TGNO-1000 was a collaborative effort among our operations in the US (Escondido, Seal Beach and Temecula) and India.”

Nikkiso Cosmodyne has extensive experience with liquid merchant plants as well as on-site gas plants like the TGNO-1000.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:

Anna Quigley
+1.951.383.3314
aquigley@cryoind.com


Posted on

Blackstone Completes Previously Announced Acquisition of Sphera, Leading Provider of ESG Software, Data, and Consulting Services

NEW YORK and CHICAGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Sphera today announced that private equity funds managed by Blackstone (NYSE: BX, “Blackstone”) have completed their previously announced acquisition of Sphera, a leading provider of environmental, social and governance (ESG) software, data and consulting services, from Genstar Capital. The transaction, which values the company at $1.4 billion, continues Blackstone’s thematic investment focus on the ESG sector and provides Sphera with capital to help accelerate its growth and product offerings.

Spanning over 80 countries with more than 3,000 customers, Sphera combines its software as a service solution with consulting services, underpinned by proprietary data, to support businesses globally to manage and mitigate ESG risk. This support is delivered through its three product lines: Environment, Health, Safety & Sustainability (EHS&S); Operational Risk Management; and Product Stewardship.

As part of Sphera’s strategic growth efforts, the company is also announcing the appointment of Kimberly Kolb as chief human resources officer (CHRO). As CHRO, Kolb will be responsible for developing and supporting Sphera’s global workforce as the organization continues to grow its footprint worldwide. She brings over 30 years of human resources, consulting and marketing experience from technology, professional service and financial services firms to the position, and held senior leadership roles at Whittman-Hart, CME Group and XR Trading.

Paul Marushka, CEO and president at Sphera, said, “As we enter this new stage, we are excited to be able to partner with Blackstone. Our achievements to date are a result of the dedication, hard work and effort of the team at Sphera. I am proud to collaborate with such a dedicated team as we take Sphera, with Blackstone’s investment and support, to the next level. This partnership with and capital injection by Blackstone will facilitate the next evolution of innovation, cementing our position as leaders and allowing us to push ahead with our vision for ESG software integration with extensive data and world-class consultancy services.”

Eli Nagler, a senior managing director at Blackstone, said: “We are excited to partner with Paul Marushka and his team to build on Sphera’s strong momentum as a trusted leader in the ESG solutions space. We look forward to supporting the company in the next phase of its growth journey as they continue to expand their product offerings and innovate to best serve their global customer base.”

Note to editors

About Sphera
Sphera creates a safer, more sustainable and productive world. We are a leading global provider of Environmental, Social and Governance (ESG) performance and risk management software, data and consulting services with a focus on Environment, Health, Safety & Sustainability (EHS&S), Operational Risk Management and Product Stewardship. Learn more about Sphera at www.sphera.com. Follow Sphera on LinkedIn.

About Blackstone
Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $684 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Contact:

Sphera Solutions, Sphera@AspectusGroup.com

Posted on

Madison Realty Capital Originates $450 Million Construction Loan for 1,098-unit Mixed Use Development in Downtown Brooklyn

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced it has provided a $450 million loan to The Rabsky Group, one of the largest residential and commercial developers in Brooklyn and Queens, to complete development of a 1,098-unit, 35-story multifamily and retail mixed-use property at 625-635 Fulton Street at the intersection of Flatbush Avenue in Downtown Brooklyn, New York.

Josh Zegen, Managing Principal and Co-Founder of Madison Realty Capital, said, “This transaction represents Madison Realty Capital’s ability to deliver speed, certainty, and execution to top-tier borrowers in highly attractive submarkets. Accordingly, we are pleased to provide The Rabsky Group, a highly sophisticated and experienced developer with significant holdings throughout the New York metropolitan area, with a large and flexible financing solution. Downtown Brooklyn is an ever-expanding neighborhood and new multifamily housing options, particularly of this caliber, will be quickly absorbed. We are glad to support a property under development that will offer significant affordable housing options and look forward to expanding our relationship with The Rabsky Group for additional projects that positively impact New York City.”

Brooklyn is New York City’s most populous borough and is home to one of the most diverse economies in the country. Proximity to major employment hubs and education centers have made Downtown Brooklyn one of New York’s fastest growing residential markets. Moreover, Downtown Brooklyn has also become a technology and innovation hub and is home to 25 percent of New York City-based tech firms. The property is located within the Brooklyn Tech Triangle, an area comprised of Downtown Brooklyn, DUMBO, and the Brooklyn Navy Yard that has emerged as New York City’s largest cluster of tech activity outside of Manhattan and is within two blocks of ten different subway lines.

Designed with two interconnected residential towers atop a five-story podium, the property will offer 590,096 rentable residential square feet across 342 studios, 492 one-bedroom and 264 two-bedroom units and 30% of the units will be affordable through the Affordable New York program. A portion of the affordable units will be part of the Inclusionary Housing Program for lower income tenants. Residents will enjoy top-of-the-line amenities including a fitness facility, spa, recreation areas, in-unit washers and dryers, lounges, and a rooftop outdoor pool with views of Manhattan and Brooklyn. In addition to best-in-class residential units the property will have 25,988 rentable square feet of retail space along Fulton Street, 250 parking spaces and 150 storage units.

The Rabsky Group is led by Simon Dushinsky, Yadler Rabinowitz, and Joel Gluck, who also contributed significant cash equity for the construction.

Henry Bodek of Galaxy Capital served as broker for the transaction.

About Madison Realty Capital 

Madison Realty Capital is a vertically integrated real estate private equity firm that manages approximately $6 billion in total assets on behalf of an institutional global investor base. Since 2004, Madison Realty Capital has completed more than $15 billion in transactions in the U.S. providing reputable borrowers with flexible and highly customized financing solutions, strong underwriting capabilities, and certainty of execution. Headquartered in New York City, with offices in Los Angeles and Miami, the firm has over 60 employees across all real estate investment, development, and property management disciplines. Madison Realty Capital has been frequently named to the Commercial Observer’s prestigious “Power 100” list of New York City real estate players and is consistently cited as a top construction lender, among other industry recognitions. To learn more, follow us on LinkedIn and visit www.madisonrealtycapital.com.

Nathaniel Garnick/Grace Cartwright
Gasthalter & Co.
(212) 257-4170
madisonrealty@gasthalter.com
Posted on

Tech Companies Datamaran and Intelex Team Up to Provide a Full-Suite ESG Software Solution

The exclusive relationship allows Intelex customers to manage the full life cycle of their ESG strategy, including Materiality Analysis and Risk Identification.

Toronto, Canada, Sept. 14, 2021 (GLOBE NEWSWIRE) — Intelex Technologies, ULC, a leading global provider of cloud-based Environmental, Health, Safety and Quality (EHSQ) management software, today announced it has entered an exclusive reseller partnership with Datamaran®, the only automated solution available to achieve a data-driven business process for external risk and materiality analysis. Working together, Datamaran and Intelex are helping customers accelerate their strategic and operational goals with a single source, fully automated and data-driven process.

Justin McElhattan, President and CEO of Intelex said, “We are very excited to partner with Datamaran to provide our customers with Datamaran’s industry-leading risk monitoring and materiality intelligence. Alongside Datamaran, we are able to offer our customers a superb experience that allows them to accelerate their ESG transformation by applying best-in-class data science and analytics.”

With this exclusive reseller partnership, Intelex customers will use Datamaran to identify, monitor and gain insights into emerging business and social issues with a dynamic risk and materiality process. The partnership provides organizations with unique risk monitoring and materiality capabilities, including Datamaran for Executives, a comprehensive solution to ensure that the most complete set of material risks are accurately captured for risk management, transparently communicated in annual disclosures and consistently reported up to the board of directors.

Mirroring Intelex’s own approach to providing scalable solutions that match customer ESG requirements, the Datamaran partnership offers customers the flexibility they need to achieve their strategic objectives. With Intelex and Datamaran together, organizations can seamlessly manage and monitor their ESG initiatives, reporting and strategy.

Companies worldwide use Datamaran’s evidence-based approach to inform their materiality, risk management, board oversight and reporting processes. This approach allows them to stay ahead of the curve, in front of the competition and at the top of their game. For an actual use case, you don’t have to look farther than Intelex parent company Fortive.

Pete Underwood, SVP and General Counsel of Fortive explains: “Datamaran continually anticipates and meets our needs, as our ESG and risk management processes evolve and mature. The platform enables a clear view of business-critical issues across the ever-changing landscape.”

With Datamaran and Intelex, senior management communicate timely and relevant information to the board of directors, move materiality from an operational exercise to a strategic process and monitor emerging trends. Using AI, Datamaran’s patented technology identifies and monitors over 400 external risk factors—including ESG, innovation and technology and geopolitical issues—on an ongoing basis by scanning the regulatory, media and corporate disclosure environments. It is the only software analytics platform available to improve risk management, annual reporting and board oversight of external risks and opportunities.

“For the past seven years, blue-chip companies have chosen Datamaran to seriously improve the way in which they go about ESG,” said Marjella Lecourt-Alma, CEO and co-founder of Datamaran. “With Intelex, we’re excited to reach an even larger group of companies. As a software provider with deep expertise in EHS, Intelex understands that ESG is now dominating the corporate market. Our full-suite ESG software solution enables companies to quickly move sustainability from project to process.”

About Datamaran: Datamaran is the only software analytics platform in the world that identifies and monitors external risks, including ESG. Trusted by blue-chip companies and top tier partners, it brings a data-driven business process for external risk and materiality analysis. In house—at any time. Datamaran’s patented technology offers real-time analytics on strategic, regulatory and reputational risks, specific to your business and value chain.

About Intelex Technologies, ULC: Intelex is a global leader in environmental, health, safety and quality (EHSQ) management software. Since 1992, Intelex employees across the globe have been committed to innovating and enabling organizations to send their employees home safely every day, leaving behind a more sustainable world to the generations that follow, and manage quality so that only the safest and highest quality products make it to market.

Intelex’s scalable, web-based platform and applications have helped clients across all industries improve business performance, mitigate organization-wide risk, and ensure sustained compliance with internationally accepted standards (e.g. ISO 9001, ISO 14001, ISO 45001) and OSHAS 18001) and regulatory requirements. Almost 1,400 customers in 195 countries trust Intelex to power their EHSQ initiatives.

Headquartered in Toronto with regional offices and employees around the world, Intelex became an Industrial Scientific company in 2019. In 2020, Intelex acquired ehsAI, provider of a SaaS-based next-wave compliance automation solution that leverages artificial intelligence and machine learning algorithms. For more information about Intelex, visit www.intelex.com.

Sandy Smith
Intelex Technologies, ULC
216-375-0484
sandy.smith@intelex.com
Posted on

Anaqua Delivers Enhanced IP Management to Bausch Health

Anaqua’s AQX platform to provide patent and trademark management with integrated IP analytics

BOSTON, Sept. 14, 2021 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property management technology provider, today announced that Bausch Health Companies Inc. has selected Anaqua’s AQX platform to deliver enhanced IP management across the health care products company’s global operations.

Bausch Health will be using Anaqua’s AQX as their primary IP management system – both for patent and trademark management – replacing their previous IP services provider. Bausch Health will take advantage of Anaqua’s broad range of IP offerings including AcclaimIP for patent analytics, Anaqua Services for patent annuities and trademark renewals, as well as AQX modules for IP contract and financial management.

Commented Bob Romeo, CEO of Anaqua: “Bausch Health is an innovative health care company delivering on its commitment to help people around the world. We are proud to be working with them and to better serve their valuable IP assets through Anaqua’s enhanced innovation and IP management solutions.”

About Anaqua
Anaqua, Inc. is a premium provider of integrated intellectual property (IP) management technology solutions and services. Anaqua’s AQX platform combines best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia. For additional information, please visit anaqua.com, or on LinkedIn.

Company Contact:
Amanda Hollis
Associate Director, Communications
Anaqua
617-375-2626
ahollis@Anaqua.com

Posted on

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse

Mont-Saint-Guibert (Belgium), September 14, 2021, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the U.S. Food and Drug Administration (FDA) has granted the Genio® bilateral hypoglossal nerve stimulation system Breakthrough Device Designation for the treatment of adult patients with moderate to severe OSA and Complete Concentric Collapse (CCC) of the soft palate.

The FDA’s Breakthrough Designation Program was created to help patients and healthcare providers receive faster access to innovative technologies that hold the potential to provide more effective treatment of irreversibly debilitating diseases or conditions. According to the FDA, OSA is an irreversibly debilitating human disease for patients with sleep apnea. Under the Program, the FDA will provide the Genio® system with priority review and interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the US.

“We are pleased to have received Breakthrough Device Designation for our proprietary Genio® system for OSA patients with CCC, recognizing that Obstructive Sleep Apnea is an irreversibly debilitating condition.” said Olivier Taelman, CEO of Nyxoah. “This Breakthrough Designation accelerates our market authorization process in the US and expands our total addressable market to include CCC patients currently contraindicated for hypoglossal nerve stimulation.”

The Breakthrough Designation is supported by data from the Company’s BETTER SLEEP trial, aimed at addressing the long-term safety and performance of the Genio® system in adult OSA patients with and without CCC.

About BETTER SLEEP Trial
BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea, or BETTER SLEEP, is a multicenter, prospective, open-label, two-group clinical trial, designed to assess the safety and performance of the Genio® system for the treatment of OSA in adult patients with and without CCC. Top-line BETTER SLEEP results showed primary safety and performance endpoints were met, with statistically significant mean reduction in the AHI score in full patient population including CCC patients. Nyxoah will submit full BETTER SLEEP study data to a medical journal for publication and announce results following further analyses.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah is seeking for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

Contacts:
Nyxoah
Fabian Suarez, Chief Financial Officer
corporate@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
IR@nyxoah.com

Attachment

Posted on

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conference on Tuesday, September 28, 2021, with a virtual presentation at 4:00 pm CET/10:00 am ET.

A live webcast and replay of this event will be available on the Company’s investors relations website at https://investors.nyxoah.com/

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah is seeking for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

Contacts:
Nyxoah
Fabian Suarez, Chief Financial Officer
fabian.suarez@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
vivian.cervantes@gilmartinir.com

Attachment

Posted on

Gates Foundation’s Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts

New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals

SEATTLE, Sept. 14, 2021 /PRNewswire/ — The Bill & Melinda Gates Foundation today launched its fifth annual Goalkeepers Report, featuring an updated global dataset illustrating the pandemic’s adverse impact on progress toward the United Nations Sustainable Development Goals (Global Goals).

This year’s report, co-authored by Bill Gates and Melinda French Gates, co-chairs of the Bill & Melinda Gates Foundation, shows that disparities caused by COVID-19 remain stark, and those who have been hardest hit by the pandemic will be the slowest to recover. Because of COVID-19, an additional 31 million people were pushed into extreme poverty in 2020 compared to 2019. And while 90% of advanced economies will regain pre-pandemic per capita income levels by next year, only a third of low- and middle-income economies are expected to do so.

Fortunately, amidst this devastation, the world stepped up to avert some of the worst-case scenarios. In last year’s Goalkeepers Report, the Institute for Health Metrics and Evaluation (IHME) predicted a drop of 14 percentage points in global vaccine coverage—effectively erasing 25 years of progress in 25 weeks. New analysis from IHME demonstrates that the decline, while still unacceptable, was only half of what was anticipated.

In the report, the co-chairs highlight the “breathtaking innovation” that was only possible because of global collaboration, commitment, and investments over decades. They acknowledge that averting the worst-case scenarios is commendable, yet they note it’s not enough. To ensure a truly equitable recovery from the pandemic, they call for long-term investments in health and economies—like the ones that led to the rapid development of the COVID-19 vaccine—to propel recovery efforts and get the world back on track to meet the Global Goals.

“[The past year] has reinforced our belief that progress is possible but not inevitable,” write the co-chairs. “If we can expand upon the best of what we’ve seen these past 18 months, we can finally put the pandemic behind us and once again accelerate progress in addressing fundamental issues like health, hunger, and climate change.”

The report highlights the disproportionate economic impact that the pandemic has had on women globally. In high- and low-income countries alike, women have been harder hit than men by the global recession that was triggered by the pandemic.

“Women face structural barriers in every corner of the world, leaving them more vulnerable to the impacts of the pandemic,” said Melinda French Gates. “By investing in women now and addressing these inequities, governments can spur a more equitable recovery while strengthening their economies against future crises. It’s not just the right thing to do—but smart policy that will benefit everyone.”

The report also illustrates how the so-called “miracle” of COVID-19 vaccines was the result of decades of investment, policies, and partnerships that established the infrastructure, talent, and ecosystems necessary to deploy them quickly. However, the systems that allowed for the unprecedented development and deployment of the COVID-19 vaccine exist primarily in wealthy countries, and as a result, the world has not benefited equally.

“The lack of equitable access to COVID-19 vaccines is a public health tragedy,” said Bill Gates. “We face the very real risk that in the future, wealthy countries and communities will begin treating COVID-19 as yet another disease of poverty. We can’t put the pandemic behind us until everyone, regardless of where they live, has access to vaccines.”

More than 80% of all COVID-19 vaccines have been administered in high- and upper-middle-income countries to date, with some securing two to three times the number needed so they can cover boosters; less than 1% of doses have been administered in low-income countries. Further, COVID-19 vaccine access has been strongly correlated with the locations where there is vaccine R&D and manufacturing capability. Though Africa is home to 17% of the world’s population, for example, it has less than 1% of the world’s vaccine manufacturing capabilities.

Ultimately, the report calls for the world to invest in R&D, infrastructure, and innovation in places closer to the people who stand to benefit.

“We must invest in local partners to strengthen the capacity of researchers and manufacturers in lower-income countries to create the vaccines and medicines they need,” said Gates Foundation CEO Mark Suzman. “The only way we will solve our greatest health challenges is by drawing on the innovation and talent of people all over the world.”

About the Bill & Melinda Gates Foundation

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Bill Gates and Melinda French Gates.

About Goalkeepers

Goalkeepers is the foundation’s campaign to accelerate progress towards the Sustainable Development Goals (Global Goals). By sharing stories and data behind the Global Goals through an annual report, we hope to inspire a new generation of leaders—Goalkeepers who raise awareness of progress, hold their leaders accountable, and drive action to achieve the Global Goals.

About the Global Goals

On September 25, 2015, at the United Nations headquarters in New York, 193 world leaders committed to the 17 Sustainable Development Goals (Global Goals). These are a series of ambitious objectives and targets to achieve three extraordinary things by 2030: end poverty, fight inequality and injustice, and fix climate change.

Media Contact: media@gatesfoundation.org                                   
Report Link: https://www.gatesfoundation.org/goalkeepers/report/2021-report/
Report Visual Assets:http://gatesfoundation.isebox.net/goalkeepers/goalkeepers-report-2021

Posted on

Zoom Announces Planned Innovations to Ignite the Next Era of Communications

Zoomtopia 2021 Highlights Customers Using Zoom Innovations to Embrace Change, Enable Hybrid Workforces, and Grow Their Businesses

SAN JOSE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) — Today, Zoom Video Communications, Inc. kicked off Zoomtopia 2021, unveiling plans for innovations across its platform designed for today’s dynamic working environments, and to ignite a new era of connection and collaboration. Zoom is transforming the trajectory of business and personal communications by advancing the way we connect, share ideas, and get more done together – regardless of location. Zoom is developing new products, features, and partnerships designed to empower and engage the modern workforce with connected workstreams.

“Innovation remains at the forefront of Zoom’s annual Zoomtopia conference,” said Daniel Newman, Principal Analyst at Futurum Research. “I am particularly impressed with how Zoom’s plans for new solutions, like Zoom Video Engagement Center and Zoom Whiteboard, could continue to broaden Zoom’s impact on different facets of our work and lives, while enabling customers to create and grow businesses entirely on its platform.”

“In the last decade, we have been honored to become the ‘go-to’ video communications platform, but there has never been a more dynamic period in the company’s history than these last 18 months,” said Eric S. Yuan, Founder and CEO at Zoom. “We have released hundreds of new features, enhancements, and capabilities this past year alone and we have exciting new features in our development pipeline. With the ability to visually brainstorm on a virtual whiteboard and collaborate with colleagues similar to an in-person experience, or the endless opportunities of live transcription and translation services powered by Artificial Intelligence (AI) – previously considered ‘futuristic’ technologies are on the verge of becoming a reality and could reshape the way we work.”

Empowering and Engaging Communities
Zoom’s recent study on the role of video communications in daily life examined people’s preferences for how they envision using this technology in a future world. Globally, the majority of respondents agree that everything will have a virtual element – including celebrations and events.

  • Zoom Events Conference is a new event type that Zoom plans to make available this fall on Zoom Events, which will allow hosts to organize multi-track and multi-day events in a sophisticated format, with rich functionality, including, event lobby, chat, networking, sponsors, surveys, recordings, analytics, and more. Zoom Events Conference will offer hosts and attendees a customizable experience with the ability to provide an engaging and connected virtual event experience.

Enabling the Modern Workforce
Zoom is working to arm customers with innovative technology solutions designed to create new opportunities for business growth. Future potential projects include:

  • Zoom Video Engagement Center (VEC): Connect your experts with your customers on video to create engaging experiences where they can build rapport and trust, and share expertise in a structured and immersive virtual environment. With industry-specific solutions, Zoom VEC will offer the same cloud-first scalability and trusted video architecture customers have come to expect from Zoom.
  • Zoom Whiteboard: Today’s hybrid, remote and colocated workforce relies on collaboration tools to be efficient and productive, and the goal for Zoom Whiteboard is to set a new standard for working smarter, together. We envision that Zoom Whiteboard will act as a digital canvas, enabling seamless, real-time and asynchronous collaboration, with the ability to interact with the whiteboard similar to an in-person experience, creating more visually engaging and efficient meeting experiences.
  • Zoom & Oculus Team Up: Zoom will be teaming up with Horizon Workrooms to bring the physical and virtual world together using Zoom. The goal is to allow users to access their Zoom Whiteboard and Zoom Meetings within the virtual Workrooms environment when this ships next year. With this collaboration, we aim to let people immerse themselves into the Zoom Whiteboard no matter what device they join from, all while in a Zoom meeting.
  • Live Translation and Transcription: Zoom meetings will become even more inclusive with the addition of real time, automated translation, as well as expansion of its existing live transcription, with support for multiple languages coming later next year. Zoom connects users across borders and continents, and these live transcription and translation features will create endless opportunities by bridging the communications gap across language barriers as well.
  • Zoom Rooms Smart Gallery: Zoom is committed to enabling the modern workforce. To foster a more inclusive hybrid, remote and colocated work experience, we plan to expand use cases of Zoom Rooms Smart Gallery for meeting spaces of all sizes by creating individual video feeds of in-room participants, so they’re viewed clearly and equally by remote employees.
  • Hot Desking: Zoom’s envisioned hot desking solution, available later this year, will allow employees to reserve desks and spaces in their offices using an interactive map and enable easy authentication to bring your personal Zoom experience to any Zoom Rooms or Zoom Phone appliance.
  • Platform Security: Security and privacy are cornerstones of the Zoom platform. To empower customers to provision and manage their own encryption keys, Zoom is developing a Bring Your Own Key (BYOK) offering, with an initial beta planned for later this year. Additionally, Zoom plans to extend End-to-end encryption (E2EE) to Zoom Phone, potentially enabling users to upgrade to E2EE during one-on-one phone calls that occur via the Zoom client in the coming year.

Connecting Workstreams
Zoom is virtually replicating the various ways we interact in real life, and beyond. Zoom Meetings, Chat, Webinars and Phone all work together as one unified communications solution, with the ability to navigate between them.

  • Zoom Apps are built to optimize meeting workflows. Later this year, we plan to make integration of Zoom Apps available throughout the platform, including Zoom Apps for Webinars, Zoom Apps for Mobile, and immersive apps, which will enable even more immersive and collaborative app experiences.
  • Zoom Chat Huddle View will potentially provide a visual layout of channels to give teams a sense of connectedness while working virtually. Channel members will potentially be able to choose a unique virtual background of their choice, chat, easily see who is in the channel, and quickly identify if they are busy or available, bringing teams together in a whole new way.
  • Zoom Phone Video Voicemails is planned to provide a more personable alternative to standard voicemails with the ability to leave video messages for colleagues, right into their voicemail inbox.
  • Zoom Continuous Collaboration could make it easier to collaborate across tools with tighter integrations across the Zoom platform and third parties. With these planned enhancements, users would benefit from the ability to share files, recordings and chats from Zoom Meetings to Zoom Chat for easy reference and collaboration on documents and integration with file sharing solutions – all without having to leave the Zoom client.
  • Zoom Widget is planned to provide a view at-a-glance schedule, that could enable users to see who is already in the meeting, and notify the host using Zoom Chat if they are running late. For people in back-to-back meetings, Zoom Widget will help them manage time, expectations, and keep their teammates in the know.

These planned innovations will help to create a more efficient, collaborative, and engaging user experience, while also simplifying processes by connecting and organizing workstreams.

Social Impact and Zoomtopia Awards

  • Zoom Cares, Zoom’s social impact arm, announced $2 million of new funding to a collection of eight global nonprofits supporting mental health among native, LGBTQ, and young people of color who have been disproportionately affected by COVID-19 and systemic racism. Zoom organized a team of seven global experts as part of its participatory grantmaking process to collaboratively decide on the nonprofits and distribution of donations.
  • Zoom is honoring select customers who made tremendous efforts to combat COVID-19 with the Zoom Delivering Hope Awards. By activating their networks, leveraging their resources, and sharing their expertise, these organizations had a massive impact on the global collective effort against the coronavirus.
  • Every year at Zoomtopia, the company highlights the creative and unique ways its customers are using Zoom with the Zoomtopia Innovation Awards. The contest recognizes the Zoom customers that most embody innovation, inspiration, and creativity in using Zoom solutions.

Zoomtopia, powered by Zoom Events Conference, features over 75 educational sessions, over 100 thought-provoking speakers, business leaders and celebrity appearances, and opportunities to network, collaborate, and learn, visit Zoomtopia.com to register and attend. The statements contained here are for informational purposes only. Any services, products or functionality referenced that are not currently available are subject to change at Zoom’s sole discretion and may not be delivered as planned or at all. Customers who purchase from Zoom should make their purchase decisions based upon currently available pricing, features and functions.

About Zoom
Zoom is for you. We help you express ideas, connect to others, and build toward a future limited only by your imagination. Our frictionless communications platform is the only one that started with video as its foundation, and we have set the standard for innovation ever since. That is why we are an intuitive, scalable, and secure choice for individuals, small businesses, and large enterprises alike. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Visit zoom.com and follow @zoom.

Zoom Public Relations
Farshad Hashmatulla
Product PR Manager
press@zoom.us

Posted on

TrueCommerce Acquires DiCentral

Acquisition creates the most feature-rich, global, cloud-based, multienterprise supply chain network

PITTSBURGH, Sept. 13, 2021 (GLOBE NEWSWIRE) — TrueCommerce, a leading global cloud provider of supply chain and trading partner connectivity, integration, and omnichannel solutions, announced today that it has acquired DiCentral, a leading global B2B and API solutions provider. This acquisition enables TrueCommerce to fuel the growth of its leading global network, deepen its solutions portfolio, and expand its global geographic footprint.

This acquisition further cements TrueCommerce’s position as a leader in the digital supply chain collaboration and connectivity space. By leveraging the combined company’s expertise in automation, digitalization, and integration, TrueCommerce is uniquely positioned to transform the way its customers do business, with value-added solutions designed to tackle complex supply chain and eCommerce challenges, streamline operations, and increase profitability.

Known for simplifying complex API and EDI business challenges, DiCentral adds 30,000 connections to TrueCommerce’s Global Commerce Network, plus nearly 5,000 customers from a diverse base. The combined TrueCommerce network now expands to 160,000 connections and nearly 18,000 customers. Combining the strengths of both companies creates an unmatched network and innovative solution offering that empowers customers to digitize, expand, and grow their businesses like never before.

“Together, we offer intuitive integrated solutions and connectivity that solve the challenges our customers face in growing their business across an increasingly digitized, global, and complex supply chain,” said John Fay, CEO of TrueCommerce.

The acquisition fuels TrueCommerce’s vision for global growth with expanded services and integrations, including:

  • Expanded cloud-based global supply chain network
  • Increased API connectivity to key 3rd party solutions
  • An enhanced set of integrated SaaS applications and tools
  • Powerful iPaaS capabilities
  • A more extensive supply chain visibility solution
  • Extended geographic footprint
  • A more comprehensive retail drop ship program
  • Tighter integration with cloud-based SMB & enterprise-level ERPs
  • Accelerated deployment and ROI for customers

“I am thrilled to be joining the TrueCommerce leadership team and working alongside John Fay and Todd Johnson to seamlessly bring the two companies together,” said Thuy Mai, CEO of DiCentral. “We see this as a win-win for both TrueCommerce and DiCentral customers. The resulting increase in global network connectivity, commerce solutions, applications, and tools provides an unmatched offering for customers looking to grow their businesses.”

Mr. Mai will become a member of the TrueCommerce executive leadership team, serving as Co-Chief Strategy Officer of TrueCommerce. Todd Johnson will serve as the new CEO of DiCentral in addition to his current role as President and COO of TrueCommerce. John Fay will continue to serve as CEO of the combined company.

“DiCentral’s offerings strengthen our multienterprise commerce network, which already empowers businesses of all sizes to grow both domestically and internationally,” said Todd Johnson, CEO of DiCentral and President and COO of TrueCommerce. “I’m looking forward to working with the DiCentral team and continuing to provide best-in-class solutions and services to our customers.”

Ryan Harper, General Partner at Welsh, Carson, Anderson & Stowe (WCAS), a leading technology-focused private equity firm that recently acquired TrueCommerce, remarked, “We are confident that TrueCommerce is on track to becoming the global leader in supply chain collaboration, connectivity and omnichannel solutions. We continue to support the strategy of combining organic growth with focused, strategic acquisitions that expand the depth and breadth of new and existing segments, geographies, and capability areas.”

WCAS acquired TrueCommerce in November 2020 from Accel-KKR (AKKR). AKKR remains a minority shareholder of TrueCommerce. DiCentral was advised by DC Advisory.

About TrueCommerce
TrueCommerce is the most complete way to connect your business across the supply chain, integrating everything from EDI, to inventory management, to fulfillment, to digital storefronts and marketplaces. We’ve revolutionized supply chain visibility and collaboration by helping organizations make the most of their omnichannel initiatives via business P2P connectivity, order management, collaborative replenishment, intelligent fulfillment, cross-functional analytics, and product information management.

The TrueCommerce Global Commerce Network can connect businesses to over 130,000 retailers, distributors, and logistics service providers. As a fully managed services provider, we also manage new trading partner onboarding, as well as the ongoing management of partner-specific mapping, labeling changes, and communications monitoring. That’s why thousands of companies—ranging from startups to the global Fortune 100, across various industries—rely on us.

TrueCommerce: Do business in every direction
For more information, visit www.truecommerce.com

About DiCentral
Founded in 2000, DiCentral is a leading global provider of business-to-business and application integration solutions, with over two decades of experience solving complex EDI and API challenges. As market conditions continue to fluctuate and technology is deployed to manage process changes, leading organizations rely on DiCentral’s cloud-based integration platform and a global team of specialized experts to integrate and leverage data across multiple cloud and on-premises systems and applications.

Headquartered in Houston, Texas, DiCentral has 11 offices worldwide, supporting customers in more than 35 countries. DiCentral utilizes a vast library of integrations with ERPs and other applications to seamlessly exchange transactional data with trading partners worldwide to maximize ROI while maintaining existing data infrastructure. DiCentral’s services and solutions are leveraged by many Fortune 1000 companies, processing over $200 billion in transactions for over 30,000 organizations worldwide. For more information, visit www.dicentral.com.

About Welsh, Carson, Anderson & Stowe
WCAS is a leading U.S. private equity firm focused on two target industries: technology and healthcare. Since its founding in 1979, the firm’s strategy has been to partner with outstanding management teams and build value for its investors through a combination of operational improvements, growth initiatives and strategic acquisitions. The firm has raised and managed funds totaling over $27 billion of committed capital. For more information, please visit www.wcas.com.

About Accel-KKR
Accel-KKR is a technology-focused investment firm with over $10 billion in capital commitments. The firm focuses on software and tech-enabled businesses, well-positioned for topline and bottom-line growth. At the core of Accel-KKR’s investment strategy is a commitment to developing strong partnerships with the management teams of its portfolio companies and a focus on building value alongside management by leveraging the significant resources available through the Accel-KKR network. Accel-KKR focuses on middle-market companies and provides a broad range of capital solutions including buyout capital, minority-growth investments, and credit alternatives. Accel-KKR also invests across a wide range of transaction types including private company recapitalizations, divisional carve-outs and going-private transactions. In 2019 and 2020, Inc. named Accel-KKR to “PE 50 – The Best Private Equity Firms for Entrepreneurs,” its annual list of founder-friendly private equity firms. Accel-KKR is headquartered in Menlo Park with offices in Atlanta and London. Visit www.accel-kkr.com to learn more.

Media Contact

Lisa Aurichio
President, BSYA
(917) 476-8366
Lisa@bsya.com

Posted on

Information on the total number of voting rights and shares

REGULATED INFORMATION

Information on the total number of voting rights and shares

Mont-Saint-Guibert (Belgium), September 12, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of 1,400,000 new warrants on September 8, 2021 and the issue of 82,500 new shares on September 10, 2021 pursuant to the exercise of subscription rights.

  • Share capital: EUR 4,384,076.09
  • Total number of securities carrying voting rights: 25,520,359 (all ordinary shares)
  • Total number of voting rights (= denominator): 25,520,359 (all relating to ordinary shares)
  • Number of rights to subscribe to securities carrying voting rights not yet issued:
    • 91 “2013 ESOP Warrants” issued on May 3, 2013 and 23 December 2014, entitling their holders to subscribe to a total number of 45,500 securities carrying voting rights (all ordinary shares);
    • 259 “2016 ESOP Warrants” issued on November 3, 2016, entitling their holders to subscribe to a total number of 129,500 securities carrying voting rights (all ordinary shares);
    • 299 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 149,500 securities carrying voting rights (all ordinary shares);
    • 520,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of520,500 securities carrying voting rights (all ordinary shares); and
    • 1,400,000 “2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,400,000 securities carrying voting rights (all ordinary shares).

For further information, please contact:

Nyxoah
Fabian Suarez, CFO
corporate@nyxoah.com
+32 (0)10 22 24 55

Gilmartin Group
Vivian Cervantes
IR@nyxoah.com

Attachment

Posted on

Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19

Independent Data Monitoring Committee Supports Expansion to Adolescents and Pregnant and Nursing Women Based on Safety and Tolerability Data from Phase 2 Lead-In

WALTHAM, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced that the independent data monitoring committee (IDMC) for the EVADE Phase 2/3 trial of ADG20 for the prevention of COVID-19 has provided a recommendation to expand Phase 3 trial enrollment to include adolescents and pregnant or nursing women, as well as to decrease the protocol-specified, post injection monitoring time. The IDMC’s assessments are based on their review of unblinded safety and tolerability data from 200 participants enrolled in the Phase 2 lead-in portion of the trial. Adagio remains blinded to the data and plans to implement the IDMC recommendations for the Phase 3 portion of the trial. EVADE is being conducted globally, including in regions where there is a high prevalence of SARS-CoV-2 variants of concern, to evaluate the ability of a single, intramuscular dose of ADG20 to prevent COVID-19 in both pre- and post-exposure settings.

“Given the urgent need for additional treatment and preventative options for COVID-19, particularly in vulnerable populations, we are pleased that an independent assessment of the safety data from the lead-in portion of EVADE supported inclusion of adolescents and pregnant or nursing women in the next phase of the study,” said Lynn Connolly, M.D., Ph.D., chief medical officer of Adagio. “Based on the potent and broad activity of ADG20 in non-clinical studies, as well as its extended half-life and ease of administration, we believe this antibody has the potential to become a preferred prophylactic option for COVID-19, particularly for vulnerable groups such as children and the immunocompromised, for whom there are currently limited or no available options.”

The EVADE trial is a global, multi-center, double-blind, placebo-controlled clinical trial evaluating ADG20 in two independent cohorts. The first cohort (post-exposure prophylaxis) is designed to assess the safety and efficacy of ADG20 compared to placebo for the prevention of COVID-19 after exposure to an individual with laboratory confirmed SARS-CoV-2 infection. The second cohort (pre-exposure prophylaxis) is designed to assess the efficacy and safety of ADG20 compared to placebo in individuals who are at increased risk for SARS-CoV-2 infection due to occupational, housing or recreational situations, and in individuals who are at increased risk of poor vaccine response, including individuals with compromised immune systems or other co-morbidities. The primary efficacy endpoint in both cohorts is the prevention of laboratory confirmed, symptomatic COVID-19. For more information on the EVADE trial, please visit https://clinicaltrials.gov/ct2/show/NCT04859517.

The clinical development program for ADG20 includes two additional trials: the ongoing Phase 1 clinical trial of ADG20 in healthy volunteers and the ongoing STAMP trial evaluating ADG20 as a treatment for high-risk individuals with mild or moderate COVID-19 (see clinicaltrials.gov).

About ADG20
ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is being developed for the prevention and treatment of COVID-19, the disease caused by SARS-CoV-2. ADG20 was designed and engineered to possess high potency and broad neutralization against SARS-CoV-2 and additional clade 1 sarbecoviruses, by targeting a highly conserved epitope in the receptor binding domain. ADG20 displays potent neutralizing activity against the original SARS-CoV-2 strain as well as all known variants of concern. ADG20 has the potential to impact viral replication and subsequent disease through multiple mechanisms of action, including direct blocking of viral entry into the host cell (neutralization) and elimination of infected host cells through Fc-mediated innate immune effector activity. ADG20 is formulated at high concentrations, enabling intramuscular administration, and was engineered to have a long half-life, with a goal of providing both rapid and durable protection. Adagio is advancing ADG20 through multiple clinical trials on a global basis.

About Adagio Therapeutics
Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with third-party contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch. For more information, please visit www.adagiotx.com.

Contacts:
Media Contact:
Dan Budwick, 1AB
Dan@1abmedia.com

Investor Contact:
Monique Allaire, THRUST Strategic Communications
monique@thrustsc.com